At Biomarx, we are pioneering cost-effective, accessible diagnostic technologies that enable early disease detection and improved patient outcomes. We are seeking strategic investors to help bring this transformative technology to market.
With a strong foundation in cutting-edge biotechnology and industry expertise, we are committed to bridging the gap between academic research and real-world clinical applications. As we embark on our first development project, we are actively seeking seed investment to accelerate innovation, expand our research capabilities, and bring our breakthrough diagnostics to market. Join us in transforming the future of healthcare—let’s make early detection the standard. Get in touch to learn more about investment opportunities.
Total Investment Required: £100,000
We are seeking an investment of £100,000 to support the development and commercialisation of our cutting-edge molecular diagnostics technology. This funding will be used to cover key development costs, researcher support, and initial intellectual property protection, ensuring a smooth transition from early-stage research to pre-market preparation.
This investment will enable the successful development, refinement, and protection of our technology, ensuring that it is well-positioned for future growth, partnerships, and market entry. We welcome discussions with investors who share our vision for transforming early disease detection and precision medicine.